Patent · US Active

Method for determining glucose concentration in tissue fluid

US8114623B2 · kind B2 · utility

0Cited by
8References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 7, 2007
Grant dateFeb 14, 2012
Priority date
Expiry dateAug 18, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B5/1473
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The invention relates to a method and a device for determining the glucose concentration in tissue fluid whereby test values for glucose and for an endogenous reference substance are detected in a sample liquid obtained by microdialysis, microperfusion or ultrafiltration, and the glucose value is corrected in accordance with the test value for the reference substance. The recovery rate for glucose is determined from a non-linear relationship with the recovery rate for the ionic reference substance, and the test value for glucose is corrected therewith. In addition, the concentration of lactate and/or pyruvate is used as a further reference substance in the sample liquid to make further corrections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.